StreetInsider.com News Articles

Form 144 Cencora, Inc. Filed by: Cleary James F

Fri, 04 Sep 2026 12:03:00 -0400

si-local-file:///var/storage/secattach/20260904/27028867.html

Form 4 Cencora, Inc. For: Sep 01 Filed by: Krikorian Lazarus

Wed, 02 Sep 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260902/27018747.html

Form 144 Cencora, Inc. Filed by: Battaglia Silvana

Tue, 01 Sep 2026 14:13:00 -0400

si-local-file:///var/storage/secattach/20260901/27012030.html

Form 4 Cencora, Inc. For: Aug 24 Filed by: Campbell Elizabeth S

Tue, 25 Aug 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260825/26974913.html

Form 4 Cencora, Inc. For: Aug 24 Filed by: Campbell Elizabeth S

Tue, 25 Aug 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260825/26974913.html

Form 144 Cencora, Inc. Filed by: Campbell Elizabeth S

Mon, 24 Aug 2026 13:31:00 -0400

si-local-file:///var/storage/secattach/20260824/26966869.html

Form 144 Cencora, Inc. Filed by: Campbell Elizabeth S

Mon, 24 Aug 2026 13:31:00 -0400

si-local-file:///var/storage/secattach/20260824/26966869.html

RBC Capital Starts Cencora Inc (COR) at Sector Perform

Wed, 19 Aug 2026 03:07:56 -0400

RBC Capital analyst Ryan Halsted initiates coverage on Cencora Inc (NYSE: COR) with a Sector Perform rating and a price target of $330.00.

The analyst comments: “Initiating at Sector Perform with $330 PT. We believe COR's pharma-aligned and integrated platform will benefit from growth in specialty pharma; however, COR lacks the differentiated high-growth, high margin businesses that excite us about competitors which keeps us sidelined. We view COR's leading specialty distribution combined with its integrated MSO network, especially retina, as well positioned to navigate IRA-driven revenue headwinds while biosimilar introductions represent margin accretion (~$185M OI by 2028). Divestitures should be a

RBC Capital Starts Cencora Inc (COR) at Sector Perform

Wed, 19 Aug 2026 03:07:56 -0400

RBC Capital analyst Ryan Halsted initiates coverage on Cencora Inc (NYSE: COR) with a Sector Perform rating and a price target of $330.00.

Form 8-K Cencora, Inc. For: Aug 13

Fri, 14 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260814/26930337.html

Form 8-K Cencora, Inc. For: Aug 13

Fri, 14 Aug 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260814/26930337.html

Cencora says Walgreens volumes shift, reaffirms guidance, shares sink

Wed, 12 Aug 2026 12:55:14 -0400

Investing.com -- Cencora confirmed its full-year fiscal 2026 adjusted diluted earnings per share guidance range of $17.75 to $17.95 on Tuesday, maintaining the outlook it previously announced.

The company's shares fell roughly 4.8% following the announcement.

Cencora disclosed that starting July 1, certain Walgreens volume moved outside the company's operations, separate from the existing prime vendor agreement. The company said its prime vendor agreement with Walgreens remains unchanged and represents the vast majority of the related business.

The volume shift from Walgreens was fully contemplated in Cencora's August 5 commentary, according to the company.

The reaffirmation was disclosed through an 8-K filing on Tuesday,

Cencora says Walgreens volumes shift, reaffirms guidance, shares sink

Wed, 12 Aug 2026 12:55:14 -0400

Investing.com -- Cencora confirmed its full-year fiscal 2026 adjusted diluted earnings per share guidance range of $17.75 to $17.95 on Tuesday, maintaining the outlook it previously announced.

The company's shares fell roughly 4.8% following the announcement.

The volume shift from Walgreens was fully contemplated in Cencora's August 5 commentary, according to the company.

The reaffirmation was disclosed through an 8-K filing on Tuesday,

Cencora says some Walgreens volume moving outside company - Bloomberg

Wed, 12 Aug 2026 12:46:34 -0400

Cencora says some Walgreens volume moving outside company - Bloomberg

Wed, 12 Aug 2026 12:46:34 -0400

Cencora says some Walgreens volume moving outside company - Bloomberg

Form 8-K Cencora, Inc. For: Aug 12

Wed, 12 Aug 2026 12:38:00 -0400

si-local-file:///var/storage/secattach/20260812/26911435.html

Form 8-K Cencora, Inc. For: Aug 12

Wed, 12 Aug 2026 12:38:00 -0400

si-local-file:///var/storage/secattach/20260812/26911435.html

Cencora Inc (COR) PT Raised to $395 at Wells Fargo

Tue, 11 Aug 2026 06:57:55 -0400

Wells Fargo analyst Stephan Baxter raised the price target on Cencora Inc (NYSE: COR) to $395.00 (from $331.00) while maintaining a Overweight rating.

Cencora Inc (COR) PT Raised to $390 at JPMorgan

Fri, 07 Aug 2026 08:57:38 -0400

JPMorgan analyst Lisa Gill raised the price target on Cencora Inc (NYSE: COR) to $390.00 (from $382.00) while maintaining a Overweight rating.

Form 144 Cencora, Inc. Filed by: Cleary James F

Thu, 06 Aug 2026 14:44:00 -0400

si-local-file:///var/storage/secattach/20260806/26882791.html

Form 144 Cencora, Inc. Filed by: Cleary James F

Thu, 06 Aug 2026 14:44:00 -0400

si-local-file:///var/storage/secattach/20260806/26882791.html

Cencora Inc (COR) PT Raised to $370 at Baird

Thu, 06 Aug 2026 08:29:18 -0400

Baird analyst Eric Coldwell raised the price target on Cencora Inc (NYSE: COR) to $370.00 (from $340.00) while maintaining a Outperform rating.

Form 10-Q Cencora, Inc. For: Jun 30

Wed, 05 Aug 2026 15:24:00 -0400

si-local-file:///var/storage/secattach/20260805/26873379.html

Form 10-Q Cencora, Inc. For: Jun 30

Wed, 05 Aug 2026 15:24:00 -0400

si-local-file:///var/storage/secattach/20260805/26873379.html

Form 8-K Cencora, Inc. For: Jul 31

Wed, 05 Aug 2026 06:46:00 -0400

si-local-file:///var/storage/secattach/20260805/26869813.html